Civitas Therapeutics
Latest round
- Series C
Last raised
- Aug 2014
Total raised
- $111M
Investors
- 12
About Civitas Therapeutics
Civitas Therapeutics Inc.Civitas Therapeutics Inc. specializes in the development of therapies for neurological disorders. Founded in 2009 and headquartered in Chelsea, US, the company was acquired by Acorda Therapeutics on September 24, 2014, for USD 525 mn.Civitas Therapeutics offers innovative therapeutic solutions designed for patients with neurological conditions. Their primary focus is on advanced treatment methodologies that utilize proprietary drug delivery systems, ensuring effective administration of medication for improved patient outcomes.Civitas Therapeutics operates under a revenue model that capitalizes on partnerships with healthcare organizations, providing access to its innovative therapies.With the acquisition in 2014, Civitas Therapeutics aims to leverage its expanded capabilities to enhance its product suite. The company is in the process of developing new therapeutic solutions expected to launch by 2025, targeting expansion into markets across Europe and Asia.
Who invested in Civitas Therapeutics
12 investors across 5 rounds
See all investors in Civitas Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Civitas Therapeutics
Who invested in Civitas Therapeutics?
Civitas Therapeutics has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Civitas Therapeutics raised?
Civitas Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Civitas Therapeutics last raise money?
Civitas Therapeutics's most recent round on record is a Series C, in Aug 2014.
What does Civitas Therapeutics do?
Civitas Therapeutics is a biotechnology company.
Where is Civitas Therapeutics headquartered?
Civitas Therapeutics is headquartered in Chelsea, US.
Which VCs invest in companies like Civitas Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Civitas Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Civitas Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.